- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Profusa clears Nasdaq compliance issues | 2 | Seeking Alpha | ||
| Di | Profusa regains compliance with Nasdaq listing requirements | 1 | Investing.com | ||
| Di | Profusa, Inc. Receives Nasdaq Compliance Determination | 121 | GlobeNewswire (Europe) | Berkeley, CA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA) (the "Company") announced today that on September 9, 2026, the Company received a letter (the "Compliance Determination... ► Artikel lesen | |
| Di | Profusa, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 31.08. | Profusa regains Nasdaq compliance; shares up | 2 | Seeking Alpha | ||
| PROFUSA Aktie jetzt für 0€ handeln | |||||
| 31.08. | Profusa erfüllt wieder die Börsenanforderungen der NASDAQ | 1 | Investing.com Deutsch | ||
| 31.08. | Profusa regains compliance with Nasdaq listing requirements | 3 | Investing.com | ||
| 31.08. | Profusa, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.08. | Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement | 278 | GlobeNewswire (Europe) | Berkeley, CA, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA) (the "Company") announced that it has received a letter (the "Notice") from the Listing Qualifications Department of The... ► Artikel lesen | |
| 20.08. | Profusa, Inc. reports Q2 results | 2 | Seeking Alpha | ||
| 20.08. | Profusa converts $4.6M debt to preferred stock ahead of G3 deal | 4 | Investing.com | ||
| 20.08. | Profusa, Inc.: Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company | 314 | GlobeNewswire (Europe) | Debt and liabilities holders have executed $10.7 million of Series A Convertible Exchange Agreements; of which $4.57 million was converted into Series A Convertible Preferred Stock Sufficient working... ► Artikel lesen | |
| 20.08. | Profusa, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 19.08. | Profusa, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.08. | Profusa to implement 1-for-4 reverse stock split | 1 | Seeking Alpha | ||
| 13.08. | Profusa, Inc.: Profusa Announces 1-for-4 Reverse Stock Split | 603 | GlobeNewswire (Europe) | BERKELEY, California, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (Nasdaq: PFSA), a commercial stage digital health company pioneering a next-generation technology platform... ► Artikel lesen | |
| 31.07. | Profusa, Inc.: Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs | 462 | GlobeNewswire (Europe) | BERKELEY, Calif., July 31, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces the signing of an Option Agreement... ► Artikel lesen | |
| 27.07. | Profusa Announces Signing Of Non-Binding Term Sheet For Acquisition Of Commercial-Stage Diagnostics Company | 2 | pulse2.com | ||
| 27.07. | Profusa inks term sheet to merge with $111M health diagnostics firm; appoints Jack Stover as CEO | 1 | Seeking Alpha | ||
| 27.07. | Profusa unterzeichnet Absichtserklärung zur Übernahme eines Diagnostikunternehmens | 2 | Investing.com Deutsch |
1 2 3 4 Weiter >>
62 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,614 | +0,07 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| HIMS & HERS HEALTH | 25,120 | +2,87 % | HIMS Bulls Should Heed This Historic Chart Signal | ||
| CERENOME | 1,680 | -4,65 % | Cerenome, Inc.: Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division | HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announces the appointment of Samantha... ► Artikel lesen | |
| HEALWELL AI | 0,451 | -1,64 % | HEALWELL AI: HEALWELL's DARWEN AI Outperforms Published Foundation Model Benchmarks and Demonstrates Real-World Patient Impact in New Peer-Reviewed Research | New research accepted for presentation at AMIA 2026 demonstrates the performance of HEALWELL's DARWEN AI-powered SMARTSuite, including clinical summarization results that outperformed published benchmarks... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,960 | +2,04 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| ORGANON | 11,880 | -0,25 % | Organon: FDA prüft Zulassungsverlängerung für Kupferspirale Miudella | ||
| VERU | 2,380 | +2,59 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,940 | -0,76 % | Clover Health Investments, Corp.: Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026 | WILMINGTON, Del., April 01, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physician enablement company committed to bringing access to great... ► Artikel lesen | |
| ELEKTA | 4,600 | +0,52 % | Dividendenbekanntmachungen (04.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAON INC US0003602069 0,1 USD 0,086 EUR ACUSHNET HOLDINGS CORP US0050981085 0,255 USD 0,2193 EUR AIA GROUP LTD HK0000069689 0... ► Artikel lesen | |
| SENSEONICS | 7,850 | -0,63 % | Senseonics sees activist investor take a major stake | ||
| IMUNON | 1,230 | -1,60 % | Imunon, Inc.: IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001 | ||
| PERSPECTIVE THERAPEUTICS | 2,416 | +2,81 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Announces Clinical Collaboration and Supply Agreement with Merck & Co., Inc. to Evaluate [212Pb]PSV359 in Combination with Keytruda (Pembrolizumab) in FAP-a Positive Solid Tumors | SEATTLE, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| AXOGEN | 39,680 | 0,00 % | Weekly Buzz: JNJ Wins FDA Nod; AXGN, HCWB Strike Deals; ROIV, AstraZeneca, GPCR Lead Clinical Trials | NEW BRUNSWICK (dpa-AFX) - Biotech and healthcare saw regulatory approvals, strategic partnerships, M&A activity, and a steady stream of clinical trial updates driving investor attention.Notable... ► Artikel lesen | |
| NIAGEN BIOSCIENCE | 2,580 | -1,53 % | Niagen Bioscience, Inc: Niagen Bioscience to Present at Longevity Investors Conference | Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate... ► Artikel lesen | |
| MYOMO | 1,130 | +7,01 % | Myomo auf H.C. Wainwright Konferenz: Strategiewechsel zu Empfehlungen treibt Wachstum an |
Das Unternehmen PROFUSA INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,620 Euro und damit -8,99 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFUSA INC finden Sie auf Wallstreet Online.